There’s been a rise of shingles cases among adults aged 25–49. Why aren’t they eligible for a free vaccine?
Articles on Shingles vaccine
Displaying all articles
A prominent Nature study and related research raise the possibility that vaccines may have a broader role in experimental therapeutics outside the realm of infectious diseases.
Gains in vaccination may reflect heightened public awareness of the importance of vaccination during the pandemic.
Middle age means staying a step ahead on both the medical and financial fronts.
Top contributors
-
Professor of Public Health, Texas A&M University
-
Research fellow in Health Systems, International Centre for Future Health Systems, UNSW
-
Professor and Department Head of Psychiatry, University of Illinois Chicago
-
Department Chair and Professor of Biochemistry and Molecular Genetics, University of Illinois Chicago
-
Senior Lecturer in Biochemistry, School of Agriculture, Biomedicine and Environment, La Trobe University
-
Tracey Banivanua Mar Senior Research Fellow in Cell and Molecular Biology, La Trobe University
-
Professor of Infectious Diseases and Global Health, University of Sydney
-
Senior Research Fellow and Team Lead for Health Technology Assessment, Centre for Health Economics, Monash University
-
Professor of Infectious Diseases, Monash University